Indeed, we have demonstrated that AD tissues and cell models display pathogenic accumulation of Aβ precursor, C99 (Pera et al. 2017), and that C99 elevations are sufficient to upregulate MAM functionality (Montesinos et al. 2020c). This evidence concerns the gene APP and Alzheimer disease.